HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EC’s Science Committee Approves Of 4-MBC In Sunscreens ... For Now

This article was originally published in The Rose Sheet

Executive Summary

After years of debate resulting in several conflicting opinions from the European Commission's Scientific Committee on Consumer Products, industry has persuaded the panel - for the time being - that 4-methylbenzylidene camphor is safe in sunscreens at concentrations up to 4 percent

You may also be interested in...



ECHA Supporting Efforts To Speed Disinfectants To European Market

The European Chemicals Agency is working to develop a centralized, expedited authorization process to increase the availability of disinfectants to consumers and healthcare professionals fighting the novel coronavirus. Meanwhile, the ECHA encourages companies to work with national authorities on single-market applications for derogations under the Biocidal Products Regulation to speed up production.

CBD Format – Spectrum Or Isolate? – Likely To Be Differentiator Tried In FDA Forum, Courts

Companies choosing between CBD options – namely broad- or full-spectrum hemp extracts or CBD isolate – need to appreciate the differences and potential legal implications, attorneys say.

NGOs Are Optimistic About Washington State’s Safer Products Regulation, For Good Reason

California’s Safer Consumer Products regime has been criticized for being too slow to address perceived dangerous chemicals and too reliant on manufacturer-led alternatives analyses. Washington state’s Safer Products program established in 2019 is designed to eliminate those alleged impediments.

UsernamePublicRestriction

Register

RS015697

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel